Hybrid Tellurium-Lignin Nanoparticles with Enhanced Antibacterial Properties
Overview
Biotechnology
Affiliations
The surge of antibiotic-resistant bacteria is leading to the loss of effectiveness of antibiotic treatment, resulting in prolonged infections and even death. Against this healthcare threat, antimicrobial nanoparticles that hamper the evolution of resistance mechanisms are promising alternatives to antibiotics. Herein, we used Kraft lignin, a poorly valorized polymer derived from plant biomass, to develop novel hybrid tellurium-lignin nanoparticles (TeLigNPs) as alternative antimicrobial agents. The sonochemically synthesized TeLigNPs are comprised of a lignin matrix with embedded Te clusters, revealing the role of lignin as both a reducing agent and a structural component. The hybrid NPs showed strong bactericidal effects against the Gram-negative and , achieving more than 5 log bacteria reduction, while they only slightly inhibited the growth of the Gram-positive . Exposure of TeLigNPs to human cells did not cause morphological changes or reduction in cell viability. Studies on the antimicrobial mechanism of action demonstrated that the novel TeLigNPs were able to disturb bacterial model membranes and generate reactive oxygen species (ROS) in Gram-negative bacteria.
Kosaristanova L, Bytesnikova Z, Fialova T, Pekarkova J, Svec P, Ondreas F J Anim Sci Biotechnol. 2024; 15(1):173.
PMID: 39707565 PMC: 11660941. DOI: 10.1186/s40104-024-01128-y.
Preparation and Biological Activity of Lignin-Silver Hybrid Nanoparticles.
Marsik D, Danda M, Otta J, Thoresen P, Mat Atkova O, Rova U ACS Omega. 2024; 9(48):47765-47787.
PMID: 39651097 PMC: 11618447. DOI: 10.1021/acsomega.4c08117.
Kim C, Lim Y, Kim Y, Murthy A, Cho H, Lee H Molecules. 2024; 29(22).
PMID: 39598787 PMC: 11597708. DOI: 10.3390/molecules29225398.
Havryliuk O, Rathee G, Blair J, Hovorukha V, Tashyrev O, Morato J Nanomaterials (Basel). 2024; 14(20).
PMID: 39452980 PMC: 11510091. DOI: 10.3390/nano14201644.
Puertas-Segura A, Ivanova K, Ivanova A, Ivanov I, Todorova K, Dimitrov P ACS Appl Mater Interfaces. 2024; 16(27):34656-34668.
PMID: 38916599 PMC: 11247429. DOI: 10.1021/acsami.4c05713.